Itchy Chicken Pox Spots

Aegis vs. Danone - Finally more transparency

ground-breaking ruling in terms of media transparency

The 7th Civil Division of the Higher Regional Court in Munich ruled that the ex-Aegis Media clients Danone received during the service time refunds of the TV marketers have to disclose. The Senate ruled that given the Aegis subsidiary Carat information must have the discounts and other benefits received by the agency from 2003 to 2005 of the TV stations or their marketing companies.

This includes the obligation to provide information associated with companies such as Carat, the purchasing company, the agency group Aegis Media Central Services. This concerns in particular according to a court order rebates and free spots, agency reimbursements and kickback payments and other benefits that were granted not only customer-related.

Danone sees this ruling as an important step towards more transparency in the media business. For the first time a court order confirms the right of customers to inspect the agency reimbursements to take. Danone now wants to submission of data by Carat "the lack of the demand charge and discounts," said company spokesman Andreas Knaut.

for Carat means the decision is a bitter defeat, since it is essentially the first instance verdict was confirmed. A review has not been specifically authorized. Besides running a further dispute the District Court of Munich between Danone and Carat for not Ingenieur cost guarantees. The claims of Danone to Carat in 2006 it amounted to about 15 million €.

published on 23.12.2009 Advertisement and promotion

Championship Belt Creator

Voltaren Gel Media Attention liver risks

FDA: Washington - The U.S. Food and Drug Administration estimates that the topical use of diclofenac may harm the liver. The manufacturer of a Voltaren ® gel was instructed to point in the product information.

on

* Communication from the FDA

http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm193047.htm

* U.S. technical information to a Voltaren ® gel

http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022122s006lbl.pdf

topical diclofenac preparations are a popular Means for external treatment of minor sports injuries such as bruises or sprains. Most users should consider ways that the drug might have after absorption through the skin, systemic side effects.

Possible consequences include the FDA severe liver injury. The announcement means we can disclose whether it actually occurred after topical application. The manufacturer of the Voltaren gel must be received in detail in the Summary of the risk.

Regular users are required to be determined within four to eight weeks after therapy, the transaminase.


© RME / aerzteblatt.de